a developer of molecular therapies for cancer treatment
Industry Biotechnology
A.I.dvisor indicates that over the last year, GNPX has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GNPX jumps, then REVB could also see price increases.
Ticker / NAME | Correlation To GNPX | 1D Price Change % | ||
---|---|---|---|---|
GNPX | 100% | -2.17% | ||
REVB - GNPX | 48% Loosely correlated | -7.83% | ||
TYRA - GNPX | 33% Poorly correlated | -5.80% | ||
BCTX - GNPX | 31% Poorly correlated | -10.07% | ||
SPRO - GNPX | 29% Poorly correlated | -2.19% | ||
SYRS - GNPX | 28% Poorly correlated | -5.49% | ||
More |
Ticker / NAME | Correlation To GNPX | 1D Price Change % |
---|---|---|
GNPX | 100% | -2.17% |
modules theme (9 stocks) | 25% Poorly correlated | +1.12% |
cancer theme (87 stocks) | 23% Poorly correlated | +0.89% |
pharmaceuticals theme (167 stocks) | 21% Poorly correlated | +0.82% |
treatment theme (61 stocks) | 17% Poorly correlated | +0.91% |